Polymeric nanoparticle encapsulating Docetaxel for prolonged and targeted delivery to breast cancer

[1]  J. Sangshetti,et al.  Extended release delivery of erlotinib glutathione nanosponge for targeting lung cancer , 2018, Artificial cells, nanomedicine, and biotechnology.

[2]  J. Sangshetti,et al.  Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation* , 2017, Drug development and industrial pharmacy.

[3]  S. Ribeiro,et al.  Synthesis and factorial design applied to a novel chitosan/sodium polyphosphate nanoparticles via ionotropic gelation as an RGD delivery system. , 2017, Carbohydrate polymers.

[4]  Y. Meng,et al.  Role of pH-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review. , 2016, Biointerphases.

[5]  Huifeng Zhang,et al.  Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Xin-guo Jiang,et al.  Preparation,-Characterization and Anti-Glioma Effects of Docetaxel-Incorporated Albumin-Lipid Nanoparticles. , 2015, Journal of biomedical nanotechnology.

[7]  H. Azzazy,et al.  Biodegradable Particulate Carrier Formulation and Tuning for Targeted Drug Delivery. , 2015, Journal of biomedical nanotechnology.

[8]  S. Chiou,et al.  Demethoxycurcumin-carrying chitosan-antibody core-shell nanoparticles with multitherapeutic efficacy toward malignant A549 lung tumor: from in vitro characterization to in vivo evaluation. , 2015, Molecular pharmaceutics.

[9]  Daehee Kim,et al.  A novel aqueous parenteral formulation of docetaxel using prodrugs. , 2014, International journal of pharmaceutics.

[10]  Linda Pastero,et al.  Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy. , 2013, International journal of pharmaceutics.

[11]  Samuel M. Cohen,et al.  Folate-decorated nanogels for targeted therapy of ovarian cancer. , 2011, Biomaterials.

[12]  K. Ulbrich,et al.  Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. , 2010, Biomaterials.

[13]  B. Strukelj,et al.  N-methylnitrosourea Induced Breast Cancer in Rat, the Histopathology of the Resulting Tumours and its Drawbacks as a Model , 2009, Pathology & Oncology Research.

[14]  Sanjay K. Jain,et al.  In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  Baorui Liu,et al.  The antitumor effect of novel docetaxel-loaded thermosensitive micelles. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  Sanjay K. Jain,et al.  Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells , 2007, Journal of drug targeting.

[17]  M. Karamouzis,et al.  Phase II study of pegylated liposomal doxorubicin (Caelyx) and docetaxel as first-line treatment in metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  Yasuo Ida,et al.  Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent. , 2004, Journal of pharmaceutical sciences.

[19]  Ping Li,et al.  Solubilization of Fluasterone in cosolvent/cyclodextrin combinations. , 2003, International journal of pharmaceutics.

[20]  F. Dosio,et al.  Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[21]  T. Park,et al.  Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[22]  I. Stamenkovic,et al.  Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites. , 2000, The American journal of pathology.

[23]  G. Prestwich,et al.  Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. , 1999, Bioconjugate chemistry.

[24]  M. Kraynak.  Pharmaceutical aspects of docetaxel. , 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[25]  M. Alonso,et al.  Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers , 1997 .

[26]  B. Leyland-Jones,et al.  Hypersensitivity reactions from taxol. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  W. Hennink,et al.  Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles. , 2015, Biomaterials.

[28]  A. Saraste,et al.  Acute Doxorubicin Cardiotoxicity Involves Cardiomyocyte Apoptosis 1 , 2000 .

[29]  F. Pinguet,et al.  In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin. , 1998, European journal of cancer.

[30]  Y. Atomi,et al.  Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity. , 1996, Journal of drug targeting.